Literature DB >> 23416061

Involvement of ASK1-p38 pathway in the pathogenesis of diabetes triggered by pancreatic ß cell exhaustion.

Kiyoshi Yamaguchi1, Kohsuke Takeda, Hisae Kadowaki, Ikumi Ueda, Yoshio Namba, Yasuyoshi Ouchi, Hideki Nishitoh, Hidenori Ichijo.   

Abstract

BACKGROUND: Diabetes mellitus is characterized by high blood glucose levels. Pancreatic ß cell death contributes to type 1 and type 2 diabetes. Akita mice, which harbor a human permanent neonatal diabetes-linked mutation (Cys96Tyr) in the insulin gene, are well established as an animal model of diabetes caused by pancreatic ß cell exhaustion. Mutant Insulin 2 protein (Ins2(C96Y)) induces endoplasmic reticulum (ER) stress and pancreatic ß cell death in Akita mice, although the molecular mechanism of Ins(C96Y)-induced cell death remains unclear.
METHODS: We investigate the mechanisms of Ins2(C96Y)-induced pancreatic ß cell death in vitro and in vivo, using p38 inhibitor (SB203580), MIN6 cell (pancreatic ß cell line), Akita mice and apoptosis signal-regulating kinase 1 (ASK1) knockout mice.
RESULTS: The expression of Ins(C96Y) activated the ASK1-p38 pathway. Deletion of ASK1 mitigated Ins(C96Y)-induced pancreatic ß cell death and delayed the onset of diabetes in Akita mice. Moreover, p38 inhibitor suppressed Ins(C96Y)-induced MIN6 cell death.
CONCLUSIONS: These findings suggest that ER stress-induced ASK1-p38 activation, which is triggered by the accumulation of Ins(C96Y), plays an important role in the pathogenesis of diabetes. GENERAL SIGNIFICANCE: Pancreatic ß cell death caused by insulin overload appears to be involved in the pathogenesis of type 1 and type 2 diabetes. Inhibition of the ASK1-p38 pathway may be an effective therapy for various types of diabetes.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416061     DOI: 10.1016/j.bbagen.2013.01.029

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders.

Authors:  So Yeong Cheon; Kyoung Joo Cho
Journal:  J Mol Med (Berl)       Date:  2019-01-07       Impact factor: 4.599

2.  Targeting apoptosis signalling kinase-1 (ASK-1) does not prevent the development of neuropathy in streptozotocin-induced diabetic mice.

Authors:  Victoria L Newton; Sumia Ali; Graham Duddy; Alan J Whitmarsh; Natalie J Gardiner
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

3.  Deletion of apoptosis signal-regulating kinase 1 (ASK1) protects pancreatic beta-cells from stress-induced death but not from glucose homeostasis alterations under pro-inflammatory conditions.

Authors:  Emilie Pepin; Arisa Higa; Carole Schuster-Klein; Catherine Bernard; Thierry Sulpice; Beatrice Guardiola; Eric Chevet; Thierry Alquier
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 4.  Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade.

Authors:  Maria Vanessa Perez-Gomez; Maria Dolores Sanchez-Niño; Ana Belen Sanz; Catalina Martín-Cleary; Marta Ruiz-Ortega; Jesus Egido; Juan F Navarro-González; Alberto Ortiz; Beatriz Fernandez-Fernandez
Journal:  J Clin Med       Date:  2015-06-18       Impact factor: 4.241

5.  Signaling pathways from the endoplasmic reticulum and their roles in disease.

Authors:  Hisae Kadowaki; Hideki Nishitoh
Journal:  Genes (Basel)       Date:  2013-07-01       Impact factor: 4.096

Review 6.  Role of the unfolded protein response in β cell compensation and failure during diabetes.

Authors:  Nabil Rabhi; Elisabet Salas; Philippe Froguel; Jean-Sébastien Annicotte
Journal:  J Diabetes Res       Date:  2014-04-09       Impact factor: 4.011

7.  Inhibition of p38 mitogen-activated protein kinase exerts a hypoglycemic effect by improving β cell function via inhibition of β cell apoptosis in db/db mice.

Authors:  Xiaowei Wei; Nan Gu; Nan Feng; Xiaohui Guo; Xiaowei Ma
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 8.  Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases.

Authors:  Toufic Kassouf; Grzegorz Sumara
Journal:  Biomolecules       Date:  2020-08-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.